ArticleScientific reports2019

Impact of the 2018 ASCO/CAP guidelines on HER2 fluorescence in situ hybridization interpretation in invasive breast cancers with immunohistochemically equivocal results.

Bo Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.